UTx-twin: Living Donor Uterus Transplantation Between Identical Twins
Sponsor
Sahlgrenska University Hospital, Sweden (Other)
Overall Status
Completed
CT.gov ID
NCT03138226
Collaborator
University Hospital Tuebingen (Other), University of Belgrade (Other)
1
1
59
0
Study Details
Study Description
Brief Summary
Living donor uterus transplantation between identical twins, with IVF before and ET several months after transplantation. The donor should have completed childbirth.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Living donor uterus transplantation between identical twins, with IVF before and ET several months after transplantation. The donor should have completed childbirth.
Study Design
Study Type:
Observational [Patient Registry]
Actual Enrollment
:
1 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Living Donor Uterus Transplantation Between Identical Twins
Actual Study Start Date
:
Jan 1, 2017
Actual Primary Completion Date
:
Dec 1, 2021
Actual Study Completion Date
:
Dec 1, 2021
Outcome Measures
Primary Outcome Measures
- Live births after uterus transplantation [5 years]
Eligibility Criteria
Criteria
Ages Eligible for Study:
20 Years
to 40 Years
Sexes Eligible for Study:
Female
Inclusion Criteria:
-
age below 40 years
-
absolute uterine factor infertility
-
BMI<30-
Exclusion Criteria:
- systemic disease
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Sahlgrenska University Hospital | Gothenburg | Sweden | 41345 |
Sponsors and Collaborators
- Sahlgrenska University Hospital, Sweden
- University Hospital Tuebingen
- University of Belgrade
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Mats Brännström,
Professor,
Sahlgrenska University Hospital, Sweden
ClinicalTrials.gov Identifier:
NCT03138226
Other Study ID Numbers:
- Twin UTx
First Posted:
May 3, 2017
Last Update Posted:
Dec 15, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mats Brännström,
Professor,
Sahlgrenska University Hospital, Sweden
Additional relevant MeSH terms: